Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Swift

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Alcoholism, Clinical and Experimental Research|September 30, 2020
Differences in Sociodemographic and Alcohol-Related Clinical Characteristics Between Treatment Seekers and Nontreatment Seekers and Their Role in Predicting Outcomes in the COMBINE Study for Alcohol Use DisorderCarolina L Haass-Koffler, Daria Piacentino, Xiaobai Li, et al.
BMJ Open|January 30, 2023
Synchronised transcranial magnetic stimulation for substance use-disordered Veterans: protocol for the pilot sham-controlled acceptability trialJonathan Jampel, McKenzie J Quinn, Jamie L Catalano, et al.
Experimental and Clinical Psychopharmacology|June 11, 2008
Olanzapine reduces urge to smoke and nicotine withdrawal symptoms in community smokersDamaris J Rohsenow, Jennifer W Tidey, Robert Miranda, et al.
Substance Abuse|May 27, 2003
Alcohol relapses associated with September 11, 2001: a case reportWilliam H Zywiak, Robert L Stout, Winston B Trefry, et al.
Pharmacogenomics and Personalized Medicine|December 11, 2012
Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapyGeorge A Kenna, Nick Roder-Hanna, Lorenzo Leggio, et al.
Journal of Substance Abuse Treatment|November 12, 2013
Motivational interviewing versus brief advice for cigarette smokers in residential alcohol treatmentDamaris J Rohsenow, Rosemarie A Martin, Peter M Monti, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 17, 2014
Pharmacotherapy for alcoholic patients with alcoholic liver diseaseCynthia L Vuittonet, Michael Halse, Lorenzo Leggio, et al.
Pharmacology, Biochemistry, and Behavior|December 25, 2012
A human laboratory pilot study with baclofen in alcoholic individualsLorenzo Leggio, William H Zywiak, John E McGeary, et al.
Journal of Abnormal Psychology|February 10, 2010
Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environmentLara A Ray, Robert Miranda, Jennifer W Tidey, et al.
Journal of Psychopharmacology (Oxford, England)|January 25, 2018
Administration of the metabotropic glutamate receptor subtype 5 allosteric modulator GET 73 with alcohol: A translational study in rats and humansCarolina L Haass-Koffler, Kimberly Goodyear, Antonella Loche, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Alcoholism, Clinical and Experimental Research|September 30, 2020
Differences in Sociodemographic and Alcohol-Related Clinical Characteristics Between Treatment Seekers and Nontreatment Seekers and Their Role in Predicting Outcomes in the COMBINE Study for Alcohol Use DisorderCarolina L Haass-Koffler, Daria Piacentino, Xiaobai Li, et al.
BMJ Open|January 30, 2023
Synchronised transcranial magnetic stimulation for substance use-disordered Veterans: protocol for the pilot sham-controlled acceptability trialJonathan Jampel, McKenzie J Quinn, Jamie L Catalano, et al.
Experimental and Clinical Psychopharmacology|June 11, 2008
Olanzapine reduces urge to smoke and nicotine withdrawal symptoms in community smokersDamaris J Rohsenow, Jennifer W Tidey, Robert Miranda, et al.
Substance Abuse|May 27, 2003
Alcohol relapses associated with September 11, 2001: a case reportWilliam H Zywiak, Robert L Stout, Winston B Trefry, et al.
Pharmacogenomics and Personalized Medicine|December 11, 2012
Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapyGeorge A Kenna, Nick Roder-Hanna, Lorenzo Leggio, et al.
Journal of Substance Abuse Treatment|November 12, 2013
Motivational interviewing versus brief advice for cigarette smokers in residential alcohol treatmentDamaris J Rohsenow, Rosemarie A Martin, Peter M Monti, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 17, 2014
Pharmacotherapy for alcoholic patients with alcoholic liver diseaseCynthia L Vuittonet, Michael Halse, Lorenzo Leggio, et al.
Pharmacology, Biochemistry, and Behavior|December 25, 2012
A human laboratory pilot study with baclofen in alcoholic individualsLorenzo Leggio, William H Zywiak, John E McGeary, et al.
Journal of Abnormal Psychology|February 10, 2010
Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environmentLara A Ray, Robert Miranda, Jennifer W Tidey, et al.
Journal of Psychopharmacology (Oxford, England)|January 25, 2018
Administration of the metabotropic glutamate receptor subtype 5 allosteric modulator GET 73 with alcohol: A translational study in rats and humansCarolina L Haass-Koffler, Kimberly Goodyear, Antonella Loche, et al.
Pageof 9